NonprofitsPioneer Valley Life Sciences Institute Of Baystate Medical

Medical Research

Pioneer Valley Life Sciences Institute Of Baystate Medical

SPRINGFIELD, MA

Total revenue

$82K

Total expenses

$227K

Net assets

$421K

Grants received

$430K

5 grants

EIN

571183126

Tax year

2023

Mission

Improve human health by developing new approaches for the diagnosis & treatment of disease.

Programs

3 programs

Breast cell repository description: normal cells from a diverse cohort of patients is needed to identify the cellular mechanisms responsible for the wide variation in responses to therapies among individuals. This effort focuses on creation of normal breast epithelial cells that reflect the variation in the population of women. Methods are used to expand the cells in vitro providing a versatile source for testing differences in sensitivity to environmental contaminants and therapeutic compounds. Accomplishments: breast cells from 500 individuals and growing. Procedures to immortalize normal breast cells from most patients have been established. We have established immortalized cell lines from normal breast epithelium from 17 donors representing diverse breast cancer risk. The cell lines are genetically stable and unique based on genetic fingerprinting. These are being used to determine differences in susceptibility to oncogenic transformation caused by chemicals and altered cell signaling.

Expenses: $54K

Biospecimen resources & molecular analysis facilitydescription: the facility maintains the equipment and personnel to provide histological services. This group also assists investigators with maintaining irb approvals for tissue procurement. Accomplishments: support services (histology, molecular analyses) has been used by investigators from umass amherst, umass medical school, baystate health systems as well as serving other academic scientists.

Expenses: $54K

Ovarian registry:description: as ovarian cancer is very difficult to screen for and thus is often not caught early enough, studies developing non-invasive blood tests for ovarian cancer are warranted. We have established a registry for women undergoing surgery for suspicious ovarian masses. We currently have 137 ovarian tissues and matching bloods from women. Of these approximately 102 have some degree of low grade or high grade malignancy.

Expenses: $54K

Financials

FY 2023

Revenue

Contributions & grants$82K
Program service revenue
Investment income
Other revenue
Total revenue$82K

Expenses

Grants paid
Salaries & benefits
Fundraising
Other expenses$227K
Total expenses$227K
Total assets$756K
Net assets$421K

People

11 listed

NameRoleCompensation

PETER REINHART PHD

CHAIR

Board

5 hrs/wk

PETER FRIEDMANN

VICE CHAIR

Board

5 hrs/wk

PATRICK SHEEHY

DIRECTOR; TREASURER (END 6/2024)

Board

5 hrs/wk

ANDREW MANGELS

DIRECTOR (END 7/2024)

Board

5 hrs/wk

KEITH PARENT

DIRECTOR

Board

5 hrs/wk

JAY STEINGRUB

DIRECTOR

Board

5 hrs/wk

LAURA VANDENBERG

DIRECTOR

Board

5 hrs/wk

D JOSEPH JERRY

DIRECTOR; EX-OFFICIO (END 8/2024)

Board

5 hrs/wk

ASHRAF KHAN MD

DIRECTOR (START 7/2024)

Board

5 hrs/wk

TASHANNA MYERS MD

DIRECTOR (START 7/2024)

Board

5 hrs/wk

RAYMOND MCCARTHY

CFO

Board

5 hrs/wk

Grants received

Showing 5 of 5

FromAmountPurposeYear
$137K
Junior Faculty Development Precision Medicine
2024
$136K
Junior Faculty Development Precision Medicine
2023
$138K
Junior Faculty Development Precision Medicine
2022

Funded by

$430K from 1 funder · 5 grants · 2022–2024

American Diabetes Association

$430K · 5 grants · 2022–2024

Details

EIN571183126
NTEE codeH92
Subsection03
Ruling date2004-08
Formed2004
Employees0
Volunteers14
PIONEER VALLEY LIFE SCIENCES INSTITUTE OF BAYSTATE MEDICAL — Mission, Financials & Grants Received | Grantivo